Header Logo

Connection

ANDREW CIVITELLO to Adult

Back to Details
This is a "connection" page, showing publications ANDREW CIVITELLO has written about Adult.
ANDREW CIVITELLO
Connection Strength
0.213
Adult
  1. Medium to long-term ventricular assist device support in adults with congenital heart disease. J Heart Lung Transplant. 2025 Feb; 44(2):278-281.
    View in: PubMed
    Score: 0.014
  2. Continuous-Flow Ventricular Assist Device Support in Adult Congenital Heart Disease: A 15-Year, Multicenter Experience of Temporary and Durable Support. ASAIO J. 2023 05 01; 69(5):429-437.
    View in: PubMed
    Score: 0.013
  3. Distinctive kidney function trajectories following left ventricular assist device implantation. J Heart Lung Transplant. 2022 12; 41(12):1798-1807.
    View in: PubMed
    Score: 0.012
  4. Genetic testing in ambulatory cardiology clinics reveals high rate of findings with clinical management implications. Genet Med. 2021 12; 23(12):2404-2414.
    View in: PubMed
    Score: 0.012
  5. Continuous-Flow Left Ventricular Assist Device Explantation After More Than 5 Years of Circulatory Support and Ventricular Reconditioning. Tex Heart Inst J. 2021 06 10; 48(2).
    View in: PubMed
    Score: 0.011
  6. Predictors of renal replacement therapy in patients with continuous flow left ventricular assist devices. J Artif Organs. 2021 Jun; 24(2):207-216.
    View in: PubMed
    Score: 0.011
  7. Gastrointestinal Bleeding After HeartMate II or HVAD Implantation: Incidence, Location, Etiology, and Effect on Survival. ASAIO J. 2020 03; 66(3):283-290.
    View in: PubMed
    Score: 0.010
  8. Outcomes of Repeat Left Ventricular Assist Device Exchange. ASAIO J. 2020 01; 66(1):64-68.
    View in: PubMed
    Score: 0.010
  9. Effect of cardiac arrest with aortic cross-clamping during left ventricular assist device implantation. Interact Cardiovasc Thorac Surg. 2020 01 01; 30(1):47-53.
    View in: PubMed
    Score: 0.010
  10. Long-Term Continuous-Flow Left Ventricular Assist Device Support After Left Ventricular Outflow Tract Closure. ASAIO J. 2019 08; 65(6):558-564.
    View in: PubMed
    Score: 0.010
  11. A Multisite Randomized Controlled Trial of a Patient-Centered Ventricular Assist Device Decision Aid (VADDA Trial). J Card Fail. 2018 Oct; 24(10):661-671.
    View in: PubMed
    Score: 0.009
  12. Left Ventricular Recovery with Explantation of Continuous-Flow Left Ventricular Assist Device after 5 Years of Support. Ann Thorac Cardiovasc Surg. 2021 Jun 20; 27(3):211-214.
    View in: PubMed
    Score: 0.009
  13. Continuous-Flow Left Ventricular Assist Device Therapy in Adults with Transposition of the Great Vessels. Ann Thorac Cardiovasc Surg. 2021 Feb 20; 27(1):64-67.
    View in: PubMed
    Score: 0.009
  14. Predictive value of preoperative serum albumin levels on outcomes in patients undergoing LVAD implantation. J Card Surg. 2018 Aug; 33(8):469-478.
    View in: PubMed
    Score: 0.009
  15. Model of End-Stage Liver Disease-eXcluding International Normalized Ratio (MELD-XI) Scoring System to Predict Outcomes in Patients Who Undergo Left Ventricular Assist Device Implantation. Ann Thorac Surg. 2018 08; 106(2):513-519.
    View in: PubMed
    Score: 0.009
  16. Bridging to a Long-Term Ventricular Assist Device With Short-Term Mechanical Circulatory Support. Artif Organs. 2018 Jun; 42(6):589-596.
    View in: PubMed
    Score: 0.009
  17. Effect of obesity on outcomes in patients undergoing implantation of continuous-flow left ventricular assist devices. J Artif Organs. 2018 Jun; 21(2):180-187.
    View in: PubMed
    Score: 0.009
  18. Continuous-Flow Left Ventricular Assist Device Implantation in Patients With a Small Left Ventricle. Ann Thorac Surg. 2018 03; 105(3):799-806.
    View in: PubMed
    Score: 0.009
  19. Continuous-flow ventricular assist device exchange is safe and effective in prolonging support time in patients with end-stage heart failure. J Thorac Cardiovasc Surg. 2015 Jan; 149(1):267-75, 278.e1.
    View in: PubMed
    Score: 0.007
  20. Trauma in patients with continuous-flow left ventricular assist devices. Am J Cardiol. 2013 Nov 01; 112(9):1520-2.
    View in: PubMed
    Score: 0.007
  21. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience. JACC Cardiovasc Interv. 2009 Feb; 2(2):91-6.
    View in: PubMed
    Score: 0.005
  22. Unprotected left main stent placement in a patient with Takayasu's arteritis: an unusual solution for an unusual disease. Tex Heart Inst J. 2006; 33(2):253-5.
    View in: PubMed
    Score: 0.004
  23. Cardiac tamponade and electrical alternans. Tex Heart Inst J. 2002; 29(1):66-7.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.